Johnson & Johnson announced today initial Phase 1 results of JNJ-79635322 (JNJ-5322), a novel investigational trispecific antibody (TsAb) in patients with relapsed or refractory multiple myeloma.

The former president spoke publicly for the first time about his cancer treatment while attending a Memorial Day service in ...

It would help the trials—and patients—if more people were tested for Alzheimer’s earlier on, so that they could be enrolled ...

During a ‘Deal or No Deal Island’ chat, Manganiello talked about the bond they created working together, and the special ...

The announcement comes at a particularly emotional time for the singer, who was diagnosed with primary brain lymphoma in late ...

Developments in artificial intelligence (AI) can help clinicians to diagnose thoracic conditions that may be miss on first glance.

Erin Patterson, the woman accused of killing her ex in-laws and a third family member by serving them a meal laced with ...

A new study, sponsored by AstraZeneca and presented at the American Society of Clinical Oncology (ASCO) annual meeting in ...

Cancer is one of the main characters in June 2025, and all eyes will be on them once Jupiter, the planet of luck, enters this ...

American voters last fall might not have realized that a Republican victory in 2024 would mean sweeping cuts to cancer ...

Fifty years after its first album, “Dreamboat Annie,” Heart beats on — albeit not without some dysrhythmia along the way.